Conclusion
In this heart failure cohort of patients with high prevalence of Chagas disease cardiomyopathy, survival was less-favorable in patients undergoing CRT upgrade compared to de novo implantations. Until further evidence is available, this result should be taken into account when evaluating upgrade therapy in Chagas disease patients with previous ventricular pacing.